Company intelligence / Profile preview

Linthin Technologies

Hong Kong Science Park, Hong Kong SARhkstp.org ↗

Ownership: Private
Development stage: Commercial

Overview

Linthin Technologies has developed MetaCAFC, the first EMG wearable test device using electronic skin in China. The product enables real-time measurement and monitoring of ECG and EMG data through a smart wearable platform that integrates proprietary AI algorithms, new materials science, and 5G IoT connectivity. The company focuses on sports medicine applications including training optimization and rehabilitation.

Therapeutic areas: Other
Modalities: DeviceWearable deviceArtificial intelligence-based diagnostic systemBioelectric system (for physiological monitoring)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Linthin Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linthin Technologies.

Explore the full profile